These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 4520112

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Drug induced alterations of the liver. Histological aspects (author's transl)].
    Desmet VJ.
    Acta Gastroenterol Belg; 1981; 44(9-10):367-74. PubMed ID: 7342616
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H, Opl G.
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Comparative evaluation of several functional tests of the liver in patients with pulmonary tuberculosis with side-reactions to tuberculostatic preparations].
    Kaminskaia GO, Karachunskiĭ MA, Kolosovskaia VP.
    Ter Arkh; 1969 Nov; 41(11):75-9. PubMed ID: 5384752
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA.
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract] [Full Text] [Related]

  • 29. [The topography of rat liver cell necrosis and proliferation after sublethal phalloidinintoxication of adult and newborn rats (author's transl)].
    Koch HK, Agostini B, Lesch R.
    Verh Dtsch Ges Pathol; 1978 Aug; 62():265-9. PubMed ID: 746843
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Toxicity of pyrazinamide in antituberculous treatments (author's transl)].
    Pretet S, Perdrizet S.
    Rev Fr Mal Respir; 1980 Aug; 8(4):307-30. PubMed ID: 6454227
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cytoplasmic crystalline regions in hepatocytes of liver biopsy specimens.
    Burns WA, Vander Weide G, Goldstein LI, Chan CH.
    Arch Pathol; 1974 Jan; 97(1):43-5. PubMed ID: 4808443
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Toxic reactions during treament with pyrazinamide in pulmonary tuberculosis].
    Radecki A, Kanwiszer H, Krzanowska E, Donderowicz A.
    Gruzlica; 1968 Apr; 36(4):315-21. PubMed ID: 4877969
    [No Abstract] [Full Text] [Related]

  • 40. Isoniazid is not always the cause of hepatitis during treatment of tuberculosis.
    van der Kooi K, Mottet JJ, Regamey C.
    Clin Infect Dis; 1994 Nov; 19(5):987-8. PubMed ID: 7893906
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.